Industry News
Plant biotech centre to develop better crops
A $20 million plant biotechnology centre to explore ways of improving agricultural sustainability and develop plants resistant to drought, frost and salinity was opened recently at the University of Melbourne.
[ + ]Incubating new technology in Queensland
UniQuest Pty Limited, The University of Queensland's main technology commercialisation company, has unveiled the University's first formal technology incubator.
[ + ]Prima hires Progen for vaccine manufacture
Brisbane's Progen Industries (ASX:PGL) will take on production of an anti-cancer therapeutic vaccine for Prima Biomed's (ASX:PRR) Cancer Vac subsidiary. [ + ]
AGT boss touts genes' athletic implications
Australian researchers have discovered two genes that are critical to understanding elite athletic performance, an Athens conference has heard. [ + ]
Biogen using Brain Resource Co platform
Sydney-based Brain Resource Company (ASX:BRC) has cracked into the biotechnology sector with a deal to provide its profiles of brain function and cognition to Biogen in the United States. [ + ]
Visiomed in spinal surgery collaboration
Diagnostics group Visiomed (ASX:VSG) has entered a German research collaboration to develop surgical navigation systems for spinal procedures. [ + ]
Melbourne trial uses adult stem cells to treat severe angina
Bone marrow stem cells have been used to treat five patients with severe angina in a Phase I clinical trial at St Vincent's Hospital in Melbourne. [ + ]
Circadian boosts neuroscience investment
Circadian Technologies (ASX:CIR) has added another string to its neuroscience bow with an investment in new Melbourne research. [ + ]
Biotechs, VCs need to get real, says UK venture capitalist
Both biotechnology companies and venture capitalists need to be more realistic about the opportunities and outcomes available to them, a British venture capitalist told a Melbourne forum yesterday. [ + ]
Criminalise human cloning, says new group
A newly-formed international consortium of scientists and lawyers has launched a bid to have human reproductive cloning declared a crime against humanity. [ + ]
Abbott disputes Peptech patent infringement
Peptech's shares (ASX:PTD) nose-dived today, dropping as low as AUD$1.23 after news that the company was embroiled in another patent dispute over its anti-TNF patents, this time with licensee Abbott Laboratories. [ + ]
Norwood on track for spin-off's UK listing
Norwood Abbey (ASX:NAL) is on track to list its immunology spin-off in the United Kingdom within six months. [ + ]
Cytochrome structure unravels photosynthesis
A complete molecular-scale picture of how plants convert sunlight to chemical energy has been obtained at Purdue University in the US, offering potential new insights into animal metabolism as well.
[ + ]GroPep finally closes Biotech Australia chapter
GroPep (ASX:GRO) has closed the book on its acquisition of Biotech Australia with the receipt of AUD$3.6 million final payment for the Roseville site. [ + ]
ComBio 2003: The hard truth about salt resistance
'Durum' means 'hard' in Latin -- but for wheatgrowers who have tried to grow high-value, high-protein durum wheats in the semi-arid regions of Victoria, SA an WA semi-arid zone, durum wheats are in the too-hard basket. [ + ]